Alembic Pharmaceuticals Limited (APLLTD) — Cash Flow-to-Debt Ratio
Alembic Pharmaceuticals Limited (APLLTD) has a Cash Flow-to-Debt Ratio of 0.13x as of September 2025, meaning its operating cash flow of Rs4.03 Billion could theoretically repay 0% of its total liabilities (Rs30.81 Billion) in one year. Explore APLLTD long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Alembic Pharmaceuticals Limited Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Alembic Pharmaceuticals Limited across 15 annual periods. Also explore APLLTD total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Alembic Pharmaceuticals Limited (2011–2025)
Year-by-year debt coverage analysis for Alembic Pharmaceuticals Limited. For market capitalisation and broader financial context, see Alembic Pharmaceuticals Limited stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | Rs879.70 Million | Rs25.83 Billion | ▼ -93.1% |
| 2024 | 0.49x | Rs8.03 Billion | Rs16.27 Billion | ▲ +23.6% |
| 2023 | 0.40x | Rs7.24 Billion | Rs18.12 Billion | ▲ +36.3% |
| 2022 | 0.29x | Rs5.52 Billion | Rs18.84 Billion | ▼ -67.1% |
| 2021 | 0.89x | Rs14.63 Billion | Rs16.42 Billion | ▲ +455.3% |
| 2020 | 0.16x | Rs4.49 Billion | Rs27.99 Billion | ▼ -59.3% |
| 2019 | 0.39x | Rs8.12 Billion | Rs20.60 Billion | ▲ +117.1% |
| 2018 | 0.18x | Rs3.12 Billion | Rs17.21 Billion | ▼ -50.6% |
| 2017 | 0.37x | Rs2.89 Billion | Rs7.85 Billion | ▼ -66.1% |
| 2016 | 1.08x | Rs9.30 Billion | Rs8.59 Billion | ▲ +377.2% |
| 2015 | 0.23x | Rs1.72 Billion | Rs7.57 Billion | ▼ -47.9% |
| 2014 | 0.44x | Rs2.36 Billion | Rs5.42 Billion | ▼ -10.4% |
| 2013 | 0.49x | Rs2.65 Billion | Rs5.45 Billion | ▲ +126.8% |
| 2012 | 0.21x | Rs1.41 Billion | Rs6.57 Billion | ▲ +22.2% |
| 2011 | 0.18x | Rs961.81 Million | Rs5.48 Billion | — |